Allen Mark Pharma Private Limited
About Allen Mark Pharma Private Limited
Data last updated:
Allen Mark Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 26 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2020PTC145246. Its GSTIN is 01AAUCA2860M1ZF (Jammu and Kashmir). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Romisa Amin and Irshad Ahmad Khan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No. 17 – 1 – 271/5/A/1 Hat Mama Bakhtawar Old Santosh Nagar, Hyderabad, Telangana, India – 500059.
As per the financials filed for FY 2024, the company reported a revenue of ₹30.16 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹5,746 (net margin -0.2%) and EBITDA of -₹309 (EBITDA margin 0%).
Company details
Contact details
Allen Mark Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressH.No. 17 – 1 – 271/5/A/1 Hat Mama Bakhtawar Old Santosh Nagar, Hyderabad, Telangana, India – 500059
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Allen Mark Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Allen Mark Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Allen Mark Pharma Private Limited, buy the company report.
Financials of Allen Mark Pharma Private Limited
FY 2024 filings availableAllen Mark Pharma Private Limited reported revenue of ₹30.16 Lakh (up 358% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 358% in the latest year. EBITDA fell 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹309 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹5,746 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0% | |||
| Net Profit Margin | -0.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Allen Mark Pharma Private Limited, buy the company report.
Board of directors of Allen Mark Pharma Private Limited
Allen Mark Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Romisa Amin | Director | 01 Jan 2024 | 2 Years 9 Months | Current |
| Irshad Ahmad Khan | Director | 26 Oct 2020 | 6 Years 0 Months | Current |
Peer comparison
Allen Mark Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Apolish Tech Private Limited | ₹30.18 Lakh (FY 2019) | -6.0% | Village Burari, Delhi, India | |||
| Orbbro Trading and Impex Private Limited | ₹30.18 Lakh (FY 2022) | Chennai, Tamil Nadu, India | ||||
| Vxa Infrastructure Private Limited | ₹30.18 Lakh (FY 2021) | -57.0% | Jhotwara, Rajasthan, India | |||
| S B Saini Bros Electricals Pvt Ltd | ₹30.17 Lakh (FY 2024) | -81.0% | Punjab, India | |||
| DN Colors Private Limited | ₹30.17 Lakh (FY 2024) | 26.0% | Khopat Thane, Maharashtra, India | |||
| Allen Mark Pharma Private Limitedthis company | ₹30.16 Lakh (FY 2024) | -₹5,746 | -0.2% | 358.0% | Hyderabad, Telangana, India | |
| Projnext Solutions Private Limited | ₹30.16 Lakh (FY 2022) | 346.0% | Gurgaon, Haryana, India | |||
| Rubra Pharmaceuticals Limited | ₹30.15 Lakh (FY 2025) | -8.0% | Telangana, India | |||
| S3s Wellness Private Limited | ₹30.15 Lakh (FY 2024) | Noida, Uttar Pradesh, India | ||||
| Avian Laboratories Private Limited | ₹30.15 Lakh (FY 2025) | 524.0% | New Delhi, Delhi, India | |||
| Airchill Aircon India Private Limited | ₹30.15 Lakh (FY 2024) | 19.0% | New Delhi, Delhi, India |
To see the full peer comparison of Allen Mark Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Allen Mark Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Allen Mark Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Allen Mark Pharma Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
Allen Mark Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 01AAUCA2860M1ZF | Jammu and Kashmir | Active | 22 Nov 2020 |
| 07AAUCA2860M1Z3 | Delhi | Active | 10 Jul 2022 |
To see the full GST registrations and return filing status of Allen Mark Pharma Private Limited, buy the company report.
Recent activity
Allen Mark Pharma Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Romisa Amin was appointed as Director on 01 Jan 2024.
Frequently asked questions
Allen Mark Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 26 October 2020 (6+ years old) and is registered under CIN U24230TG2020PTC145246.
Allen Mark Pharma has 2 current directors:
- Romisa Amin - Director
- Irshad Ahmad Khan - Director
The latest financial statements of Allen Mark Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Allen Mark Pharma is 01AAUCA2860M1ZF, registered in Jammu and Kashmir. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 07AAUCA2860M1Z3 (Delhi).
The CIN (Corporate Identification Number) of Allen Mark Pharma is U24230TG2020PTC145246. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Allen Mark Pharma was incorporated on 26 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Allen Mark Pharma by revenue are Apolish Tech Private Limited, Orbbro Trading and Impex Private Limited, Vxa Infrastructure Private Limited, S B Saini Bros Electricals Pvt Ltd, DN Colors Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Romisa Amin was appointed as Director on 01 Jan 2024. Shehryar Ahmed Khan ceased to be Director on 01 Jan 2024. Akhtar Rasool Rather ceased to be Director on 01 Apr 2023. Allen Mark Pharma has 4 board changes on record in total.
The registered office of Allen Mark Pharma is at H.No. 17 – 1 – 2715A1 Hat Mama Bakhtawar Old Santosh Nagar, Hyderabad, Telangana, India – 500059.
Allen Mark Pharma operates in the chemicals industry, in the manufacturing segment.
Allen Mark Pharma can be reached at its registered office: H.No. 17 – 1 – 2715A1 Hat Mama Bakhtawar Old Santosh Nagar, Hyderabad, Telangana, India – 500059.